Moderna Inc. buy UBS Group AG
Start price
24.10.24
/
50%
€48.59
Target price
24.10.25
€99.80
Performance (%)
-43.29%
Price
16.07.25
€27.56
Summary
This prediction is currently active. Massive losses of -43.29% have been the result for the BUY prediction by UBS_Group_AG. This prediction currently runs until 24.10.25. The prediction end date can be changed by UBS_Group_AG at any time. UBS_Group_AG has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Moderna Inc. | -1.572% | -1.572% |
| iShares Core DAX® | -1.691% | 2.604% |
| iShares Nasdaq 100 | 0.913% | 3.716% |
| iShares Nikkei 225® | -2.346% | -1.208% |
| iShares S&P 500 | 0.732% | 3.130% |
Comments by UBS_Group_AG for this prediction
In the thread Moderna Inc. diskutieren
Moderna, Inc. (NASDAQ: MRNA) had its price target lowered by analysts at UBS Group AG from $140.00 to $108.00. They now have a "buy" rating on the stock.
Ratings data for MRNA provided by MarketBeat